The quantitative analyses demonstrated a significant increase in PMS2 protein expression from the untreated CRC sections compared with sections treated with 25 mg/kg aspirin (p = 0.0023) and aspirin plus FOLFOX concurrently (p = 0.0081; Fig 9I). This evidence concerns the gene PMS2 and colorectal carcinoma.